These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37054523)

  • 1. Elucidation of conserved multi-epitope vaccine against
    Dikhit MR; Sen A
    J Biomol Struct Dyn; 2024; 42(3):1293-1306. PubMed ID: 37054523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of multi-epitope based vaccine against
    Nayak SS; Sethi G; Ramadas K
    J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes.
    Khan MAA; Ami JQ; Faisal K; Chowdhury R; Ghosh P; Hossain F; Abd El Wahed A; Mondal D
    Parasit Vectors; 2020 Apr; 13(1):196. PubMed ID: 32295617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory algorithm to devise multi-epitope subunit vaccine by investigating Leishmania donovani membrane proteins.
    Khatoon N; Pandey RK; Ojha R; Aathmanathan VS; Krishnan M; Prajapati VK
    J Biomol Struct Dyn; 2019 Jun; 37(9):2381-2393. PubMed ID: 30047323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-silico design of an immunoinformatics based multi-epitope vaccine against Leishmania donovani.
    Saha S; Vashishtha S; Kundu B; Ghosh M
    BMC Bioinformatics; 2022 Aug; 23(1):319. PubMed ID: 35931960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
    Kashyap M; Jaiswal V; Farooq U
    Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling mRNA-based vaccine YFV.E1988 against yellow fever virus E-protein using immuno-informatics and reverse vaccinology approach.
    Khan NT; Zinnia MA; Islam ABMMK
    J Biomol Struct Dyn; 2023 Mar; 41(5):1617-1638. PubMed ID: 34994279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoinformatics based design and prediction of proteome-wide killer cell epitopes of
    Kashif M; Hira SK; Manna PP
    J Biomol Struct Dyn; 2022; 40(21):10578-10591. PubMed ID: 34219625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross-immunity against human visceral and cutaneous leishmaniasis: an immunoinformatics-based approach.
    Bhattacharjee M; Banerjee M; Mukherjee A
    J Mol Model; 2023 Mar; 29(4):99. PubMed ID: 36928431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300.
    Jalal K; Khan K; Uddin R
    Immunol Res; 2023 Apr; 71(2):247-266. PubMed ID: 36459272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design peptide and multi-epitope protein vaccine candidates against monkeypox virus using reverse vaccinology approach: an in-silico study.
    Jahantigh HR; Shahbazi B; Gouklai H; Van der Weken H; Gharibi Z; Rezaei Z; Habibi M; Ahmadi K
    J Biomol Struct Dyn; 2023; 41(23):14398-14418. PubMed ID: 37154825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasite.
    Yadav S; Prakash J; Shukla H; Das KC; Tripathi T; Dubey VK
    Pathog Glob Health; 2020 Dec; 114(8):471-481. PubMed ID: 33161887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential vaccine targets for elicitation of host immune cells against SARS-CoV-2 by reverse vaccinology approach.
    Yasmin S; Ansari MY; Pandey K; Dikhit MR
    Int J Biol Macromol; 2024 Apr; 265(Pt 2):130754. PubMed ID: 38508555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoinformatics-based multi-epitope containing fused polypeptide vaccine design against visceral leishmaniasis with high immunogenicity and TLR binding.
    Kumar P; Kumar P; Shrivastava A; Dar MA; Lokhande KB; Singh N; Singh A; Velayutham R; Mandal D
    Int J Biol Macromol; 2023 Dec; 253(Pt 8):127567. PubMed ID: 37866569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a multi-epitope vaccine against six Nocardia species based on reverse vaccinology combined with immunoinformatics.
    Zhu F; Tan C; Li C; Ma S; Wen H; Yang H; Rao M; Zhang P; Peng W; Cui Y; Chen J; Pan P
    Front Immunol; 2023; 14():1100188. PubMed ID: 36845087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome based screening of epitope ensemble vaccine candidates against dreadful visceral leishmaniasis using immunoinformatics approach.
    Singh G; Pritam M; Banerjee M; Singh AK; Singh SP
    Microb Pathog; 2019 Nov; 136():103704. PubMed ID: 31479726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring staphylococcal superantigens to design a potential multi-epitope vaccine against
    Rahman S; Sarkar K; Das AK
    J Biomol Struct Dyn; 2023; 41(22):13098-13112. PubMed ID: 36729064
    [No Abstract]   [Full Text] [Related]  

  • 18. Designing of cytotoxic T lymphocyte-based multi-epitope vaccine against SARS-CoV2: a reverse vaccinology approach.
    Vivekanandam R; Rajagopalan K; Jeevanandam M; Ganesan H; Jagannathan V; Selvan Christyraj JD; Kalimuthu K; Selvan Christyraj JRS; Mohan M
    J Biomol Struct Dyn; 2022; 40(24):13711-13726. PubMed ID: 34696708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an
    Enayatkhani M; Hasaniazad M; Faezi S; Gouklani H; Davoodian P; Ahmadi N; Einakian MA; Karmostaji A; Ahmadi K
    J Biomol Struct Dyn; 2021 May; 39(8):2857-2872. PubMed ID: 32295479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunoprophylactic evaluation of
    Pandey RK; Dikhit MR; Lokhande KB; Pandey K; Das P; Bimal S
    J Biomol Struct Dyn; 2022 Aug; 40(13):6086-6096. PubMed ID: 33602055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.